臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 51661110 在线人数 : 972 教育部委托研究计画计画执行:国立台湾大学图书馆

搜寻范围

进阶搜寻

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jhe cyuan guo"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 1-18 / 18 (共1页)
1
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2022-09-21T23:32:19Z	B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma	JHE-CYUAN GUO; CHIA-LANG HSU; YEN-LIN HUANG; Chia-Chi Lin; TA-CHEN HUANG; Wu, I. Chen; Lin, Chen Yuan; Lien, Ming Yu; HUNG-YANG KUO; ANN-LII CHENG; CHIH-HUNG HSU
臺大學術典藏	2022-09-21T23:32:18Z	Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma	JHE-CYUAN GUO; Chia-Chi Lin; CHIA-LANG HSU; TA-CHEN HUANG; HUNG-YANG KUO; Lin, Chen Yuan; Lien, Ming Yu; ANN-LII CHENG; CHIH-HUNG HSU
臺大學術典藏	2022-06-14T23:24:04Z	Embracing anti-PD-1 immunotherapy in the treatment of esophageal cancer: Implications of positive phase III trials in advanced and resected esophageal cancer	HUNG-YANG KUO; JHE-CYUAN GUO; CHIH-HUNG HSU
臺大學術典藏	2021-09-10T01:40:07Z	Durable Response of Metastatic Tumor to Erlotinib and Capecitabine in a Patient with Pancreatic Adenocarcinoma	JHE-CYUAN GUO; Jo-Pai Chen
臺大學術典藏	2021-08-18T07:39:09Z	Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma	JHE-CYUAN GUO; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; Yeh K.-H.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2021-08-18T07:39:09Z	Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: A retrospective study	JHE-CYUAN GUO; Yang S.-H.
臺大學術典藏	2021-08-18T07:39:08Z	Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer	Yang S.-H.; Kuo T.-C.; Wu H.; JHE-CYUAN GUO; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2021-08-18T07:39:08Z	Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer	Yang S.-H.; JHE-CYUAN GUO; Yeh K.-H.; Tien Y.-W.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2021-08-18T07:39:07Z	Response to Nivolumab as Salvage Therapy in a Patient with Thymic Carcinoma	Yang P.-C.; JHE-CYUAN GUO; Hsieh M.-S.; Lin C.-C.; Hsu C.-H.
臺大學術典藏	2021-08-18T07:39:07Z	Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosis	JHE-CYUAN GUO; Chang C.-C.; Yang C.-Y.; Liao B.-C.; Liau J.-Y.; Chang C.-H.; Yeh K.-H.
臺大學術典藏	2021-08-18T07:39:07Z	Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy	Yang S.-H.; Lee J.-C.; JHE-CYUAN GUO; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2021-08-18T07:39:06Z	Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma	JHE-CYUAN GUO; Tsai Y.-C.; Pu Y.-S.
臺大學術典藏	2021-08-18T07:39:06Z	Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy	JHE-CYUAN GUO; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; Yeh K.-H.; Hsu C.-H.; Lee J.-M.
臺大學術典藏	2021-08-18T07:39:05Z	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; JHE-CYUAN GUO; Liu T.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-08-18T07:39:05Z	Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors	JHE-CYUAN GUO; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H.
臺大學術典藏	2021-08-18T07:39:04Z	Rational combination with an immunotherapy backbone in genitourinary cancers	JHE-CYUAN GUO; Lin C.-C.
臺大學術典藏	2021-08-18T07:39:04Z	Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients	Yang S.-H.; JHE-CYUAN GUO; Hsu C.; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2021-08-18T07:39:03Z	Anti-PD-1 immunotherapy in advanced esophageal squamous cell carcinoma: A long-awaited breakthrough finally arrives	Kuo H.-Y.; JHE-CYUAN GUO; Hsu C.-H.

显示项目 1-18 / 18 (共1页)
1
每页显示[10|25|50]项目